Sign in
Not yet taking people in SwedenPhase 1

Scan tracer 68Ga-ATH001 in lungs of healthy people and people with scleroderma lung disease

Tests a PET scan tracer in healthy adults and adults with SSc-ILD.

Key facts

Who runs it
Antaros Medical AB
Where
Uppsala, SwedenSee the 2 sites
Registry title
Exploratory, non-randomized, 3-group, microdosing clinical trial to investigate Gallium-68 (68Ga) labeled Platelet-Derived Growth Factor Beta (PDGFRß) targeting Positron Emission Tomography (PET) tracer (68Ga-ATH001) binding in the lungs in healthy participants versus participants with Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD)
Status
Not yet recruiting
Phase
Phase 1
People taking part
15 people, planned
Started
1 Apr 2026
Expected to end
31 Mar 2027
Type of study
Interventional
Record updated
11 March 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for healthy adults and adults with systemic sclerosis-associated interstitial lung disease (SSc-ILD). It studies how a PET scan tracer called 68Ga-ATH001 binds in the lungs.

Age
18 years or older
Sex
All sexes can join.
Disease stage
Adults with systemic sclerosis-associated interstitial lung disease (SSc-ILD), and healthy participants for comparison. The record gives no stage or severity.

Where in Sweden

  • CTC Clinical Trial Consultants ABUppsala, SwedenNot yet recruiting
  • Uppsala University HospitalUppsala, SwedenNot yet recruiting

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Plain-language title
Scan tracer 68Ga-ATH001 in lungs of healthy people and people with scleroderma lung diseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
11 March 2026